<DOC>
	<DOCNO>NCT02234778</DOCNO>
	<brief_summary>The purpose study determine safety effectiveness Tissue Genesis® Icellator Cell Isolation System™ Critical Limb Ischemia . The Icellator System™ device remove certain cell adipose ( fat ) tissue use treat patient blockages artery low leg may require future amputation , cause severe peripheral artery disease ( PAD ) . The purpose study determine treatment cell remove Icellator System™ device reduce number major amputation death six month time period .</brief_summary>
	<brief_title>Evaluation Tissue Genesis® Icellator Cell Isolation System™ Treat Critical Limb Ischemia</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<criteria>Critical limb ischemia ( CLI ) , define ischemic pain rest ( Rutherford Category 4 ) minor tissue loss limb ( Rutherford Category 5 ) , either toe artery occlusive pressure &lt; 50 mmHg TBI ≤ 0.5 ankle artery occlusion pressure ≤ 60 mm Hg ABI ≤ 0.5 No reasonable open endovascular surgical option determine treat vascular specialist Competent give consent Age 21 year great Females child bear potential agree use acceptable method contraception duration trial . Sexually active male agree use accept effective method contraception duration trial . All diabetic subject undergo baseline 12month followup retinal examination conduct specialist No current malignancy history previous malignancy within last five year , exception adequately treat nonmelanoma cutaneous carcinoma ( basal cell squamous cell carcinoma skin ) . Major tissue loss index limb ( Rutherford Category 6 ) Limb revascularization surgery within 45 day enrollment study Subjects le 15 % body fat measure caliper electrical impedance Subjects le 2 cm x 2 cm roll subcutaneous abdominal fat , pinch examiner 's finger , subject supine position Poorly control diabetes mellitus evidence HbA1C &gt; 10 % . Diabetic subject must evidence glycosylated hemoglobin test ( HbA1C ) perform within last 30 day . Uncompensated congestive heart failure ( New York Heart Association Class IV ) and/or condition preclude general anesthesia . Myocardial infarction stroke within last 90 day . Elevated liver function test ( AST ALT twice upper limit normal ) . Hematologic abnormality . Disease central nervous system and/or condition impair cognitive function . History two episode pulmonary embolus documented deep venous thrombosis ( DVT ) ( Duplex US venography ) index extremity history DVT index extremity without evidence clot resolution ( Duplex US venography ) Infection index leg Pregnant lactating female . Prior enrollment , woman childbearing potential must negative urine pregnancy test . Lower extremity venous disease lymphedema pit edema index leg Osteomyelitis index leg Existing HIV diagnosis Known terminal disease process life expectancy le one year Subjects , investigator 's opinion , require amputation within 30 day Uncorrected stenosis ( e ) great 50 % common and/or external iliac artery and/or common femoral artery index leg Presence clinical condition opinion PI sponsor make patient suitable participate trial</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>critical limb ischemia</keyword>
	<keyword>autologous stromal vascular fraction</keyword>
</DOC>